Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers

Apr 1, 2025 - 02:00
Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
The drug stock is higher over the past month while the S&P 500 has pulled back sharply.